Home › Funds › AUCTUS ADVISORS LLC › CATX

AUCTUS ADVISORS LLC position in CATX

PERSPECTIVE THERAPEUTICS INC · Health Care

AUCTUS ADVISORS LLC reported holding 37,359 shares of CATX (PERSPECTIVE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$103K, representing 0.08% of its reported portfolio and ranking #30 among its reported holdings. AUCTUS ADVISORS LLC has disclosed CATX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)37.36K sh
Reported value held$102.74K
Portfolio Weight0.08%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How AUCTUS ADVISORS LLC's CATX position evolved

AUCTUS ADVISORS LLC first disclosed a stake in CATX in Q4 2025 at 31,673 shares (US$87K). The position peaked in Q3 2026 at 37,359 shares, worth US$103K. Across 4 filings, AUCTUS ADVISORS LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 37,359 shares valued at US$103K — an increase of 17,015 shares quarter over quarter.. Notable position changes include a 51% trim in Q1 2026 (shares fell 18% over the following quarter), a 31% increase in Q2 2026 (shares fell 19% over the following quarter), a 84% increase in Q3 2026 (shares fell 58% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 31.67K $87.10K New
Q1 2026 15.55K $64.83K Reduce
Q2 2026 20.34K $69.37K Add
Q3 2026 37.36K $102.74K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CATX and 13F data

CATX (PERSPECTIVE THERAPEUTICS INC) is a Health Care company. 40 other funds we track also report a position in CATX — the largest reported positions include TCG Crossover Management, LLC (US$27.0M), Commodore Capital LP (US$21.6M), Avidity Partners Management LP (US$21.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CATX

All CATX fund holders →

FAQ

How long has AUCTUS ADVISORS LLC held CATX?

AUCTUS ADVISORS LLC has disclosed CATX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is AUCTUS ADVISORS LLC's current position in CATX?

As of Q3 2026, AUCTUS ADVISORS LLC holds 37.36K shares of CATX (PERSPECTIVE THERAPEUTICS INC), valued at $102.74K, representing 0.08% of its reported portfolio and ranking #30.

Has AUCTUS ADVISORS LLC been buying or selling CATX?

In the latest 13F filing (Q3 2026), AUCTUS ADVISORS LLC increased its position in CATX. The position peaked in Q3 2026 at 37.36K shares.

Which other funds hold CATX?

Other major institutional holders of CATX include TCG Crossover Management, LLC, Commodore Capital LP, Avidity Partners Management LP, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.